Compare, Analyse Biocon Ltd with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs TEVA PHARMA (Israel) - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    TEVA PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-19
TEVA PHARMA
Dec-13
BIOCON /
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs7073,190-   
Low Rs5542,771-   
Sales per share (Unadj.) Rs91.91,830.7-  
Earnings per share (Unadj.) Rs16.7114.4-  
Cash flow per share (Unadj.) Rs24.2262.3-  
Dividends per share (Unadj.) Rs1.00100.11-  
Dividend yield (eoy) %0.23.4 4.7%  
Book value per share (Unadj.) Rs101.62,033.5-  
Shares outstanding (eoy) m600.00848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.91.6 421.4%   
Avg P/E ratio x37.726.1 144.8%  
P/CF ratio (eoy) x26.111.4 229.6%  
Price / Book Value ratio x6.21.5 423.3%  
Dividend payout %6.087.5 6.8%   
Avg Mkt Cap Rs m378,3302,527,362 15.0%   
No. of employees `0006.144.9 13.6%   
Total wages/salary Rs m11,6530-   
Avg. sales/employee Rs Th8,994.334,539.9 26.0%   
Avg. wages/employee Rs Th1,900.70-   
Avg. net profit/employee Rs Th1,635.32,157.7 75.8%   
INCOME DATA
Net Sales Rs m55,1441,552,396 3.6%  
Other income Rs m1,4440-   
Total revenues Rs m56,5881,552,396 3.6%   
Gross profit Rs m15,883425,124 3.7%  
Depreciation Rs m4,478125,482 3.6%   
Interest Rs m70930,492 2.3%   
Profit before tax Rs m12,140269,151 4.5%   
Minority Interest Rs m91,223 0.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-176,683 0.0%   
Tax Rs m2,123-3,286 -64.6%   
Profit after tax Rs m10,02696,977 10.3%  
Gross profit margin %28.827.4 105.2%  
Effective tax rate %17.5-1.2 -1,432.4%   
Net profit margin %18.26.2 291.0%  
BALANCE SHEET DATA
Current assets Rs m48,2281,048,482 4.6%   
Current liabilities Rs m30,376914,365 3.3%   
Net working cap to sales %32.48.6 374.7%  
Current ratio x1.61.1 138.5%  
Inventory Days Days6891 75.2%  
Debtors Days Days8696 89.1%  
Net fixed assets Rs m64,130507,047 12.6%   
Share capital Rs m3,0003,821 78.5%   
"Free" reserves Rs m57,9800-   
Net worth Rs m60,9801,724,417 3.5%   
Long term debt Rs m15,766793,775 2.0%   
Total assets Rs m121,9243,547,722 3.4%  
Interest coverage x18.19.8 184.4%   
Debt to equity ratio x0.30.5 56.2%  
Sales to assets ratio x0.50.4 103.4%   
Return on assets %8.83.6 245.1%  
Return on equity %16.45.6 292.4%  
Return on capital %16.84.9 339.7%  
Exports to sales %28.10-   
Imports to sales %18.90-   
Net fx Rs m5,1070-   
CASH FLOW
From Operations Rs m11,546247,372 4.7%  
From Investments Rs m-7,138-87,654 8.1%  
From Financial Activity Rs m-2,417-296,739 0.8%  
Net Cashflow Rs m2,103-137,021 -1.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 76.42 Rs / USD

Compare BIOCON With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare BIOCON With: AUROBINDO PHARMA  VENUS REMEDIES  DR. REDDYS LAB  DR. DATSONS LABS  DIVIS LABORATORIES  



Today's Market

Sensex Ends 674 Points Lower; Banking and Finance Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure throughout the day and ended lower. Investors were worried about the economic impact and uncertainty over the coronavirus pandemic.

Related Views On News

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock (Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

One Stock that is All Charged Up for the Post Coronavirus Rebound (The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

BIOCON SHARE PRICE


Apr 3, 2020 (Close)

TRACK BIOCON

MORE ON BIOCON

BIOCON 5-YR ANALYSIS

COMPARE BIOCON WITH

OTHER USEFUL LINKS

MARKET STATS